國立成功大學 |
2023 |
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
|
Su, Y.-Y.;Chiang, N.-J.;Chang, J.S.;Wang, Y.-W.;Shen, B.-N.;Li, Y.-J.;Hwang, D.-Y.;Shan, Y.-S.;Chen, L.-T. |
臺大學術典藏 |
2021-08-31T06:42:20Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang T.C.; Shiah H.S.; Yang C.H.; Yeh K.H.; ANN-LII CHENG; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T. |
臺大學術典藏 |
2021-01-28T01:06:31Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang T.C.; Shiah H.S.; Yang C.H.; KUN-HUEI YEH; Cheng A.L.; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T. |
臺大學術典藏 |
2020-05-26T09:26:56Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chen L.T.;Chang J.Y;Chiang N.J;Yeh C.G;Wang Y.W;Shen B.N;Cheng A.L;Yeh K.H;Chih-Hsin Yang;Shiah H.S;Chang T.C; Chang T.C; Shiah H.S; CHIH-HSIN YANG; Yeh K.H; Cheng A.L; Shen B.N; Wang Y.W; Yeh C.G; Chiang N.J; Chang J.Y; Chen L.T. |
臺大學術典藏 |
2020-02-10T09:00:45Z |
MicroRNA396-targeted SHORT VEGETATIVE PHASE is required to repress flowering and is related to the development of abnormal flower symptoms by the phyllody symptoms1 effector1
|
SHIH-SHUN LIN; Lin S.-S.; Shen B.-N.; Yang C.-Y.; Huang Y.-H.; Lin C.-P.; Lin Y.-Y.; Hsu H.-C.; Wang C.-N.; Liu L.-Y.D. |
臺大學術典藏 |
2020-02-10T09:00:41Z |
Identification of miRNAs and their targets in the liverwort Marchantia polymorpha by integrating RNA-Seq and degradome analyses
|
Lin P.-C.; Lu C.-W.; Shen B.-N.; Lee G.-Z.; Bowman J.L.; Arteaga-Vazquez M.A.; Daisy Liu L.-Y.; Hong S.-F.; Lo C.-F.; Su G.-M.; Kohchi T.; Ishizaki K.; Zachgo S.; Althoff F.; Takenaka M.; Yamato K.T.; Lin S.-S.; SHIH-SHUN LIN |
臺大學術典藏 |
2020-02-10T09:00:37Z |
Gene-to-gene network analysis of the mediation of plant innate immunity by the eliciting plant response-like 1 (Epl1) elicitor of trichoderma formosa
|
Cheng C.-H.; Shen B.-N.; Shang Q.-W.; Liu L.-Y.D.; Peng K.-C.; Chen Y.-H.; Chen F.-F.; Hu S.-F.; Wang Y.-T.; Wang H.-C.; Wu H.-Y.; Lo C.-T.; Lin S.-S.; SHIH-SHUN LIN |
臺大學術典藏 |
2020-01-17T03:09:39Z |
Identification of miRNAs and their targets in the liverwort Marchantia polymorpha by integrating RNA-Seq and degradome analyses
|
Ishizaki K.; Zachgo S.; Althoff F.; Takenaka M.; Yamato K.T.; Lin S.-S.; LI-YU LIU; Su G.-M.; Kohchi T.; Lo C.-F.; Hong S.-F.; Daisy Liu L.-Y.; Arteaga-Vazquez M.A.; Bowman J.L.; Lee G.-Z.; Shen B.-N.; Lu C.-W.; Lin P.-C. |
臺大學術典藏 |
2020-01-17T03:09:36Z |
Gene-to-gene network analysis of the mediation of plant innate immunity by the eliciting plant response-like 1 (Epl1) elicitor of trichoderma formosa
|
Liu L.-Y.D.; Shang Q.-W.; Shen B.-N.; Cheng C.-H.; Cheng C.-H.;Shen B.-N.;Shang Q.-W.;Liu L.-Y.D.;Peng K.-C.;Chen Y.-H.;Chen F.-F.;Hu S.-F.;Wang Y.-T.;Wang H.-C.;Wu H.-Y.;Lo C.-T.;Lin S.-S.; Peng K.-C.; Chen Y.-H.; Chen F.-F.; Hu S.-F.; Wang Y.-T.; Wang H.-C.; Wu H.-Y.; Lo C.-T.; Lin S.-S.; LI-YU LIU |
國立成功大學 |
2019 |
Structural insights into the interaction between phytoplasmal effector causing phyllody 1 and MADS transcription factors
|
Liao, Y.-T.;Lin, S.-S.;Lin, S.-J.;Sun, W.-T.;Shen, B.-N.;Cheng, H.-P.;Lin, C.-P.;Ko, T.-P.;Chen, Y.-F.;Wang, H.-C. |
臺大學術典藏 |
2018-09-10T15:34:22Z |
Identification of miRNAs and their targets in the liverwort Marchantia polymorpha by integrating RNA-Seq and degradome analyses
|
Lu, C.-W.; Shen, B.-N.; Lee, G.-Z.; Bowman, J.L.; Arteaga-Vazquez, M.A.; Daisy Liu, L.-Y.; Hong, S.-F.; Lo, C.-F.; Su, G.-M.; Kohchi, T.; Ishizaki, K.; Zachgo, S.; Althoff, F.; Takenaka, M.; Yamato, K.T.; Lin, S.-S.; Lin, P.-C.; SHIH-SHUN LIN et al. |
臺大學術典藏 |
2018-09-10T15:22:08Z |
MicroRNA396-targeted SHORT VEGETATIVE PHASE is required to repress flowering and is related to the development of abnormal flower symptoms by the phyllody symptoms1 effector1
|
Yang, C.-Y.; Huang, Y.-H.; Lin, C.-P.; Lin, Y.-Y.; Hsu, H.-C.; Wang, C.-N.; Liu, L.-Y.D.; Shen, B.-N.; Lin, S.-S.; SHIH-SHUN LIN; CHUN-NENG WANG; CHAN-PIN LIN; LI-YU LIU |
國立成功大學 |
2015-03 |
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang, T. C.; Shiah, H. S.; Yang, C. H.; Yeh, K. H.; Cheng, A. L.; Shen, B. N.; Wang, Y. W.; Yeh, C. G.; Chiang, N. J.; Chang, J. Y.; Chen, L. T. |